Evaluation of 99mTc-Labeled Bevacizumab–N-HYNIC Conjugate in Human Ovarian Tumor Xenografts

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2IBa0v3
via IFTTT